P218 Drug repurposing screen of Food and Drug Administration-approved medicines identifies novel anti-inflammatory and NF-kB inhibitory activity of the tyrosine kinase inhibitor sunitinib malate
Abstract Background/Aims Macrophage-mediated inflammation is a driver of both acute inflammatory responses and chronic inflammatory conditions such as rheumatoid arthritis. Drug repurposing is an attractive strategy for the development of novel anti-inflammatory therapeutics. Currently used anti-inf...
Gespeichert in:
| Veröffentlicht in: | Rheumatology (Oxford, England) England), 2022-04, Vol.61 (Supplement_1) |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!